Get started
Work

Supplemental Figure 3 from Early Changes in Circulating Cell-Free KRAS G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients

Year: 2023
Type: supplementary-materials
Abstract: Supplemental Figure 3: Baseline AF% of patients with complete clearance and patients with incomplete clearance at C2.
DOI: 10.1158/1078-0432.23629224.v1
Authors: Cloud P. Paweletz, Grace A. Heavey, Yanan Kuang, Emily Durlacher, Thian Kheoh, Richard C. Chao, Alexander I. Spira, Konstantinos Leventakos, Melissa L. Johnson, Sai-Hong Ignatius Ou, Gregory J. Riely, Kenna Anderes, Wenjing Yang, James G. Christensen, Pasi A. Jänne
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4383217817
Cites:
Cited by:
Related to: 10